

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 5.80298560 |
| 2 | lysine catabolic process (GO:0006554) | 5.80298560 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.70414104 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.70414104 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.66529390 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.66529390 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.36463275 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.16196708 |
| 9 | fatty acid beta-oxidation (GO:0006635) | 5.13490005 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.06675250 |
| 11 | amino-acid betaine metabolic process (GO:0006577) | 4.93920807 |
| 12 | cysteine metabolic process (GO:0006534) | 4.83366085 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82139127 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.81418440 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.79940809 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 4.74672160 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.71741316 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.71741316 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.71741316 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 4.71176907 |
| 21 | fatty acid oxidation (GO:0019395) | 4.71095018 |
| 22 | branched-chain amino acid catabolic process (GO:0009083) | 4.70797522 |
| 23 | regulation of sequestering of triglyceride (GO:0010889) | 4.63448223 |
| 24 | lipid oxidation (GO:0034440) | 4.63409722 |
| 25 | valine metabolic process (GO:0006573) | 4.62792014 |
| 26 | 2-oxoglutarate metabolic process (GO:0006103) | 4.57006105 |
| 27 | fatty acid catabolic process (GO:0009062) | 4.56435263 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.55767997 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.52034188 |
| 30 | fatty acid transmembrane transport (GO:1902001) | 4.48471602 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.46374128 |
| 32 | tryptophan metabolic process (GO:0006568) | 4.46284395 |
| 33 | carnitine metabolic process (GO:0009437) | 4.44573264 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.42222168 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 4.41441784 |
| 36 | short-chain fatty acid metabolic process (GO:0046459) | 4.35364949 |
| 37 | branched-chain amino acid metabolic process (GO:0009081) | 4.35080263 |
| 38 | carnitine shuttle (GO:0006853) | 4.30563651 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 4.29810419 |
| 40 | monocarboxylic acid catabolic process (GO:0072329) | 4.23588158 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.20911583 |
| 42 | urea metabolic process (GO:0019627) | 4.17818422 |
| 43 | urea cycle (GO:0000050) | 4.17818422 |
| 44 | proline biosynthetic process (GO:0006561) | 4.10118871 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.07939507 |
| 46 | complement activation, alternative pathway (GO:0006957) | 4.03751474 |
| 47 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.02599307 |
| 48 | biotin metabolic process (GO:0006768) | 4.00548249 |
| 49 | ethanol oxidation (GO:0006069) | 3.99957822 |
| 50 | acylglycerol homeostasis (GO:0055090) | 3.91512318 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.91512318 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 3.90438786 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 3.90278992 |
| 54 | positive regulation of fatty acid oxidation (GO:0046321) | 3.90250303 |
| 55 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.90180322 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 3.88978311 |
| 57 | NADH metabolic process (GO:0006734) | 3.88623606 |
| 58 | regulation of fatty acid oxidation (GO:0046320) | 3.87969421 |
| 59 | protein carboxylation (GO:0018214) | 3.87906720 |
| 60 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.87906720 |
| 61 | organic acid catabolic process (GO:0016054) | 3.87886427 |
| 62 | carboxylic acid catabolic process (GO:0046395) | 3.87886427 |
| 63 | ketone body metabolic process (GO:1902224) | 3.87869249 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.87717981 |
| 65 | proteasome assembly (GO:0043248) | 3.86803127 |
| 66 | regulation of protein activation cascade (GO:2000257) | 3.86632229 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.84410250 |
| 68 | tricarboxylic acid metabolic process (GO:0072350) | 3.82338793 |
| 69 | glycine metabolic process (GO:0006544) | 3.78506270 |
| 70 | bile acid metabolic process (GO:0008206) | 3.76187805 |
| 71 | oxidative phosphorylation (GO:0006119) | 3.74283001 |
| 72 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.73630642 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 3.71476177 |
| 74 | succinate metabolic process (GO:0006105) | 3.69403762 |
| 75 | regulation of fibrinolysis (GO:0051917) | 3.69001982 |
| 76 | positive regulation of lipid catabolic process (GO:0050996) | 3.68362219 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 3.66312050 |
| 78 | regulation of complement activation (GO:0030449) | 3.64701563 |
| 79 | cellular glucuronidation (GO:0052695) | 3.58501934 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 3.57061819 |
| 81 | macromolecular complex remodeling (GO:0034367) | 3.57061819 |
| 82 | plasma lipoprotein particle remodeling (GO:0034369) | 3.57061819 |
| 83 | coenzyme catabolic process (GO:0009109) | 3.48176595 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.46210370 |
| 85 | oxaloacetate metabolic process (GO:0006107) | 3.45427367 |
| 86 | amino-acid betaine transport (GO:0015838) | 3.45347325 |
| 87 | carnitine transport (GO:0015879) | 3.45347325 |
| 88 | tyrosine metabolic process (GO:0006570) | 3.45036784 |
| 89 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.44567332 |
| 90 | carnitine transmembrane transport (GO:1902603) | 3.44491236 |
| 91 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.42871512 |
| 92 | reverse cholesterol transport (GO:0043691) | 3.42074563 |
| 93 | regulation of cholesterol metabolic process (GO:0090181) | 3.40022039 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.38854795 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.36681998 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.35700538 |
| 97 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.34076046 |
| 98 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.32631398 |
| 99 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.31673305 |
| 100 | aldehyde catabolic process (GO:0046185) | 3.30485000 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.25940240 |
| 102 | indolalkylamine metabolic process (GO:0006586) | 3.25342850 |
| 103 | phospholipid efflux (GO:0033700) | 3.25071078 |
| 104 | negative regulation of sterol transport (GO:0032372) | 3.24924075 |
| 105 | negative regulation of cholesterol transport (GO:0032375) | 3.24924075 |
| 106 | small molecule catabolic process (GO:0044282) | 3.23478565 |
| 107 | DNA strand elongation (GO:0022616) | 3.22749907 |
| 108 | formation of translation preinitiation complex (GO:0001731) | 3.19010905 |
| 109 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.16527912 |
| 110 | ribosome assembly (GO:0042255) | 3.15436845 |
| 111 | proline metabolic process (GO:0006560) | 3.14443455 |
| 112 | COPI coating of Golgi vesicle (GO:0048205) | 3.10492787 |
| 113 | Golgi transport vesicle coating (GO:0048200) | 3.10492787 |
| 114 | polyketide metabolic process (GO:0030638) | 3.03094507 |
| 115 | doxorubicin metabolic process (GO:0044598) | 3.03094507 |
| 116 | daunorubicin metabolic process (GO:0044597) | 3.03094507 |
| 117 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.01169461 |
| 118 | regulation of translational fidelity (GO:0006450) | 2.97843040 |
| 119 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.96338132 |
| 120 | ATP synthesis coupled proton transport (GO:0015986) | 2.95824947 |
| 121 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.95824947 |
| 122 | tetrahydrofolate metabolic process (GO:0046653) | 2.92525984 |
| 123 | mitotic chromosome condensation (GO:0007076) | 2.91079645 |
| 124 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.90189852 |
| 125 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.85737797 |
| 126 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.85580137 |
| 127 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.85146246 |
| 128 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.82509898 |
| 129 | maturation of SSU-rRNA (GO:0030490) | 2.80641091 |
| 130 | protein maturation by protein folding (GO:0022417) | 2.78036812 |
| 131 | * respiratory electron transport chain (GO:0022904) | 2.76552152 |
| 132 | purine nucleobase biosynthetic process (GO:0009113) | 2.72085129 |
| 133 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.71492193 |
| 134 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.71354446 |
| 135 | negative regulation of ligase activity (GO:0051352) | 2.71058046 |
| 136 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71058046 |
| 137 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.69535568 |
| 138 | * electron transport chain (GO:0022900) | 2.69516464 |
| 139 | mitotic metaphase plate congression (GO:0007080) | 2.67928721 |
| 140 | folic acid-containing compound metabolic process (GO:0006760) | 2.63810625 |
| 141 | regulation of mitochondrial translation (GO:0070129) | 2.63655579 |
| 142 | ribosomal small subunit biogenesis (GO:0042274) | 2.63543891 |
| 143 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.63469521 |
| 144 | telomere maintenance via recombination (GO:0000722) | 2.61978831 |
| 145 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.61458142 |
| 146 | glucuronate metabolic process (GO:0019585) | 2.59686806 |
| 147 | uronic acid metabolic process (GO:0006063) | 2.59686806 |
| 148 | blood coagulation, intrinsic pathway (GO:0007597) | 2.59311435 |
| 149 | CENP-A containing nucleosome assembly (GO:0034080) | 2.58761219 |
| 150 | ribosomal large subunit biogenesis (GO:0042273) | 2.58448146 |
| 151 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.57215023 |
| 152 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.56579235 |
| 153 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.55613088 |
| 154 | protein localization to chromosome, centromeric region (GO:0071459) | 2.54056583 |
| 155 | amino acid salvage (GO:0043102) | 2.54028822 |
| 156 | L-methionine salvage (GO:0071267) | 2.54028822 |
| 157 | L-methionine biosynthetic process (GO:0071265) | 2.54028822 |
| 158 | AMP metabolic process (GO:0046033) | 2.53866200 |
| 159 | gluconeogenesis (GO:0006094) | 2.53489856 |
| 160 | protein neddylation (GO:0045116) | 2.51055638 |
| 161 | aerobic respiration (GO:0009060) | 2.50957760 |
| 162 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.50220832 |
| 163 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.50220832 |
| 164 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.49428606 |
| 165 | glycoside metabolic process (GO:0016137) | 2.48566407 |
| 166 | pteridine-containing compound metabolic process (GO:0042558) | 2.47515173 |
| 167 | nuclear pore organization (GO:0006999) | 2.47276957 |
| 168 | methionine metabolic process (GO:0006555) | 2.43846797 |
| 169 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.43259161 |
| 170 | epoxygenase P450 pathway (GO:0019373) | 2.42292096 |
| 171 | alpha-amino acid biosynthetic process (GO:1901607) | 2.42220711 |
| 172 | monosaccharide biosynthetic process (GO:0046364) | 2.42086944 |
| 173 | tRNA aminoacylation for protein translation (GO:0006418) | 2.42069220 |
| 174 | protein localization to kinetochore (GO:0034501) | 2.42061061 |
| 175 | nucleobase biosynthetic process (GO:0046112) | 2.41934645 |
| 176 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.41483276 |
| 177 | folic acid metabolic process (GO:0046655) | 2.40793664 |
| 178 | L-serine metabolic process (GO:0006563) | 2.40698132 |
| 179 | positive regulation of ligase activity (GO:0051351) | 2.40193509 |
| 180 | amino acid activation (GO:0043038) | 2.38820911 |
| 181 | tRNA aminoacylation (GO:0043039) | 2.38820911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.56608642 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.26027731 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.69858117 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.04070861 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.90620966 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.11817808 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.00833401 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.23154367 |
| 9 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.07854855 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.03928192 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.20615013 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.10543655 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.02078971 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.59884424 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.54818186 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.53602560 |
| 17 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.43428825 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.42126511 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.42099000 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.38574102 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34071128 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.30854727 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.15890726 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.11840009 |
| 25 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.09399231 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.02159308 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.99863089 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.91709716 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.81713879 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.78631390 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77323878 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75224409 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74805098 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71679753 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71519289 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.69938294 |
| 37 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.69302493 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68329833 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64389056 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62981697 |
| 41 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.61040667 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.60768926 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.60693968 |
| 44 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.60349903 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59694067 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.56478003 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52548322 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51739249 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50026238 |
| 50 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49592180 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40018824 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37095186 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33365212 |
| 54 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32937306 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29623139 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28920712 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26233362 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25760787 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25484906 |
| 60 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25110054 |
| 61 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24841154 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.23501948 |
| 63 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21998938 |
| 64 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19447593 |
| 65 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17870841 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16090552 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15158186 |
| 68 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.15126014 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13354659 |
| 70 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.12457420 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12344272 |
| 72 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11588636 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11444090 |
| 74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.08670599 |
| 75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06196470 |
| 76 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05988220 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02730817 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01876931 |
| 79 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.01439458 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01303766 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00489662 |
| 82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99320694 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98613562 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97939894 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94633288 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94117510 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93541197 |
| 88 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93401873 |
| 89 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93401873 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93314602 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93113683 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91112054 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90414358 |
| 94 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90037065 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89406349 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87957495 |
| 97 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87586094 |
| 98 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.86392717 |
| 99 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85910244 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.85649599 |
| 101 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.85032182 |
| 102 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.83549291 |
| 103 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83325008 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83173657 |
| 105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82886695 |
| 106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81978295 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81681919 |
| 108 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.80697913 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80037993 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79660959 |
| 111 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.79024668 |
| 112 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78778599 |
| 113 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.78453557 |
| 114 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.78262746 |
| 115 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73617286 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.73316788 |
| 117 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72939166 |
| 118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70081187 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69677440 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69377355 |
| 121 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68694699 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66969437 |
| 123 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.66782602 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66589789 |
| 125 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.65491137 |
| 126 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.64816658 |
| 127 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.63744449 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62648227 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62273147 |
| 130 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.62106281 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61502982 |
| 132 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.61465382 |
| 133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.60950767 |
| 134 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.60758103 |
| 135 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.60636127 |
| 136 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60186121 |
| 137 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.58994193 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58891175 |
| 139 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.58858514 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57889996 |
| 141 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.55968601 |
| 142 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55702026 |
| 143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55069995 |
| 144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.54273997 |
| 145 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54251972 |
| 146 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.53860928 |
| 147 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.53463522 |
| 148 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53265420 |
| 149 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.53010934 |
| 150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.52870912 |
| 151 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.52341275 |
| 152 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.52223940 |
| 153 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.51382564 |
| 154 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50944915 |
| 155 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50619173 |
| 156 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.50046937 |
| 157 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.49876024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.27628227 |
| 2 | MP0005360_urolithiasis | 6.03823717 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.04323959 |
| 4 | MP0005365_abnormal_bile_salt | 4.82042411 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.03900581 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.84835424 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.10303598 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.04264942 |
| 9 | MP0003252_abnormal_bile_duct | 2.95560839 |
| 10 | MP0005332_abnormal_amino_acid | 2.90993376 |
| 11 | MP0003718_maternal_effect | 2.83960615 |
| 12 | MP0003195_calcinosis | 2.82048785 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.79336327 |
| 14 | MP0009840_abnormal_foam_cell | 2.74644098 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.74031393 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.71827943 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.44993528 |
| 18 | MP0005670_abnormal_white_adipose | 2.43137990 |
| 19 | MP0003646_muscle_fatigue | 2.30254102 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.30182603 |
| 21 | MP0004130_abnormal_muscle_cell | 2.25428679 |
| 22 | MP0005083_abnormal_biliary_tract | 2.18005173 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 2.17440686 |
| 24 | MP0003077_abnormal_cell_cycle | 2.15836475 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.10742326 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.10214568 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.02973235 |
| 28 | MP0000609_abnormal_liver_physiology | 1.98779593 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.91533550 |
| 30 | MP0003186_abnormal_redox_activity | 1.90206636 |
| 31 | MP0008932_abnormal_embryonic_tissue | 1.89865073 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.86895408 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.85632821 |
| 34 | MP0008058_abnormal_DNA_repair | 1.81452157 |
| 35 | MP0004233_abnormal_muscle_weight | 1.71402953 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.70464464 |
| 37 | MP0003941_abnormal_skin_development | 1.68529053 |
| 38 | MP0005330_cardiomyopathy | 1.66013719 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62162813 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.61239266 |
| 41 | MP0001764_abnormal_homeostasis | 1.57744057 |
| 42 | MP0002971_abnormal_brown_adipose | 1.54770121 |
| 43 | MP0005451_abnormal_body_composition | 1.51637876 |
| 44 | MP0001730_embryonic_growth_arrest | 1.50485581 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.47822761 |
| 46 | MP0004084_abnormal_cardiac_muscle | 1.46600906 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.45091742 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.40608378 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.35105700 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.34096094 |
| 51 | MP0008007_abnormal_cellular_replicative | 1.32057992 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.24831872 |
| 53 | MP0006035_abnormal_mitochondrial_morpho | 1.21237647 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20573242 |
| 55 | MP0005501_abnormal_skin_physiology | 1.19103127 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.18804835 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.18698782 |
| 58 | MP0009697_abnormal_copulation | 1.17448567 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.16022037 |
| 60 | MP0001881_abnormal_mammary_gland | 1.15260336 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.11239657 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.11223473 |
| 63 | MP0000598_abnormal_liver_morphology | 1.10632716 |
| 64 | MP0000350_abnormal_cell_proliferation | 1.09356000 |
| 65 | MP0000749_muscle_degeneration | 1.09208224 |
| 66 | MP0005385_cardiovascular_system_phenoty | 1.07163416 |
| 67 | MP0001544_abnormal_cardiovascular_syste | 1.07163416 |
| 68 | MP0000358_abnormal_cell_content/ | 1.05663129 |
| 69 | MP0003868_abnormal_feces_composition | 1.03143103 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.02709064 |
| 71 | MP0005266_abnormal_metabolism | 1.02375864 |
| 72 | MP0005535_abnormal_body_temperature | 1.01787395 |
| 73 | MP0005375_adipose_tissue_phenotype | 1.01562805 |
| 74 | MP0004087_abnormal_muscle_fiber | 1.00360605 |
| 75 | MP0004043_abnormal_pH_regulation | 0.99416277 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.98951267 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.98504613 |
| 78 | MP0001756_abnormal_urination | 0.98282313 |
| 79 | MP0003786_premature_aging | 0.97349000 |
| 80 | MP0001697_abnormal_embryo_size | 0.97181456 |
| 81 | MP0005334_abnormal_fat_pad | 0.96197362 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.95566366 |
| 83 | MP0002972_abnormal_cardiac_muscle | 0.95442775 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.94755518 |
| 85 | MP0009763_increased_sensitivity_to | 0.93408991 |
| 86 | MP0006138_congestive_heart_failure | 0.92689759 |
| 87 | MP0002269_muscular_atrophy | 0.92434251 |
| 88 | MP0005380_embryogenesis_phenotype | 0.92096026 |
| 89 | MP0001672_abnormal_embryogenesis/_devel | 0.92096026 |
| 90 | MP0000751_myopathy | 0.91818039 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.88991349 |
| 92 | MP0010630_abnormal_cardiac_muscle | 0.88786833 |
| 93 | MP0003011_delayed_dark_adaptation | 0.88194409 |
| 94 | MP0002080_prenatal_lethality | 0.87789972 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.86594724 |
| 96 | MP0009764_decreased_sensitivity_to | 0.86130996 |
| 97 | MP0003984_embryonic_growth_retardation | 0.84849008 |
| 98 | MP0001661_extended_life_span | 0.84713667 |
| 99 | MP0009115_abnormal_fat_cell | 0.83361993 |
| 100 | MP0000313_abnormal_cell_death | 0.82474604 |
| 101 | MP0008469_abnormal_protein_level | 0.81823561 |
| 102 | MP0001853_heart_inflammation | 0.81741854 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.81544215 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.81494313 |
| 105 | MP0002088_abnormal_embryonic_growth/wei | 0.81133047 |
| 106 | MP0000490_abnormal_crypts_of | 0.80793182 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.80176798 |
| 108 | MP0002970_abnormal_white_adipose | 0.78944073 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.76866718 |
| 110 | MP0005647_abnormal_sex_gland | 0.76011892 |
| 111 | MP0002160_abnormal_reproductive_system | 0.75586416 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.75216213 |
| 113 | MP0005187_abnormal_penis_morphology | 0.75180243 |
| 114 | MP0003315_abnormal_perineum_morphology | 0.74361599 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.73970985 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.73487563 |
| 117 | MP0010307_abnormal_tumor_latency | 0.72676828 |
| 118 | MP0003724_increased_susceptibility_to | 0.72005656 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.71155027 |
| 120 | MP0002254_reproductive_system_inflammat | 0.69630307 |
| 121 | MP0002876_abnormal_thyroid_physiology | 0.69578723 |
| 122 | MP0008057_abnormal_DNA_replication | 0.69274922 |
| 123 | MP0000343_altered_response_to | 0.69058716 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.66802345 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.65893610 |
| 126 | MP0005448_abnormal_energy_balance | 0.63748760 |
| 127 | MP0004147_increased_porphyrin_level | 0.59821140 |
| 128 | MP0003828_pulmonary_edema | 0.57635427 |
| 129 | MP0005165_increased_susceptibility_to | 0.57153037 |
| 130 | MP0002796_impaired_skin_barrier | 0.53744371 |
| 131 | MP0000747_muscle_weakness | 0.53125571 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.52481569 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.52222199 |
| 134 | MP0008438_abnormal_cutaneous_collagen | 0.51144554 |
| 135 | MP0002106_abnormal_muscle_physiology | 0.51052381 |
| 136 | MP0000604_amyloidosis | 0.50003540 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.49859511 |
| 138 | MP0005408_hypopigmentation | 0.48490154 |
| 139 | MP0003567_abnormal_fetal_cardiomyocyte | 0.46744242 |
| 140 | MP0004484_altered_response_of | 0.45915697 |
| 141 | MP0005395_other_phenotype | 0.45690871 |
| 142 | MP0005275_abnormal_skin_tensile | 0.45456773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.35357893 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.07134828 |
| 3 | Hyperammonemia (HP:0001987) | 5.00689209 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.79177660 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 4.79177660 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.78025385 |
| 7 | * Abnormality of fatty-acid metabolism (HP:0004359) | 4.75408097 |
| 8 | Xanthomatosis (HP:0000991) | 4.66393728 |
| 9 | * Hypoglycemic coma (HP:0001325) | 4.59666043 |
| 10 | Deep venous thrombosis (HP:0002625) | 4.57973780 |
| 11 | Ketosis (HP:0001946) | 4.57648604 |
| 12 | Hyperglycinemia (HP:0002154) | 4.49320204 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.35631266 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.23074163 |
| 15 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.22855321 |
| 16 | * Dicarboxylic aciduria (HP:0003215) | 4.22855321 |
| 17 | Ketoacidosis (HP:0001993) | 4.19952037 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 4.11555549 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.04099629 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.87653702 |
| 21 | Myoglobinuria (HP:0002913) | 3.82939325 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.77692952 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.75064159 |
| 24 | Cerebral edema (HP:0002181) | 3.65013840 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.60441242 |
| 26 | Complement deficiency (HP:0004431) | 3.53761958 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.53147054 |
| 28 | Abnormality of serum amino acid levels (HP:0003112) | 3.46605705 |
| 29 | Lethargy (HP:0001254) | 3.45121576 |
| 30 | Abnormal gallbladder physiology (HP:0012438) | 3.42370286 |
| 31 | Cholecystitis (HP:0001082) | 3.42370286 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.41823036 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.40878637 |
| 34 | Metabolic acidosis (HP:0001942) | 3.29183706 |
| 35 | Epidermoid cyst (HP:0200040) | 3.26395996 |
| 36 | * Hepatic necrosis (HP:0002605) | 3.22984312 |
| 37 | Increased muscle lipid content (HP:0009058) | 3.03252755 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.01790626 |
| 39 | Acute encephalopathy (HP:0006846) | 2.98504771 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 2.95173584 |
| 41 | * Generalized aminoaciduria (HP:0002909) | 2.88862487 |
| 42 | Nemaline bodies (HP:0003798) | 2.88674303 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84600584 |
| 44 | Joint hemorrhage (HP:0005261) | 2.80239602 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.75742538 |
| 46 | Fat malabsorption (HP:0002630) | 2.75542620 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.74871811 |
| 48 | Gout (HP:0001997) | 2.74472488 |
| 49 | * Vomiting (HP:0002013) | 2.73009562 |
| 50 | Muscle fiber inclusion bodies (HP:0100299) | 2.70983693 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.70795659 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.69258031 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.68153109 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67810128 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.64643760 |
| 56 | Palpitations (HP:0001962) | 2.64253271 |
| 57 | * Nausea (HP:0002018) | 2.64046133 |
| 58 | Reduced antithrombin III activity (HP:0001976) | 2.63353140 |
| 59 | Increased serum pyruvate (HP:0003542) | 2.62900905 |
| 60 | Abnormality of glycolysis (HP:0004366) | 2.62900905 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60051589 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.59632269 |
| 63 | Abnormality of complement system (HP:0005339) | 2.56192166 |
| 64 | Lactic acidosis (HP:0003128) | 2.55198654 |
| 65 | Exercise intolerance (HP:0003546) | 2.54775276 |
| 66 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.51945308 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51470526 |
| 68 | Hepatocellular necrosis (HP:0001404) | 2.49580528 |
| 69 | * Proximal tubulopathy (HP:0000114) | 2.49075926 |
| 70 | Increased serum lactate (HP:0002151) | 2.47761991 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.39272597 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.39272597 |
| 73 | Methylmalonic aciduria (HP:0012120) | 2.38340894 |
| 74 | Hyperuricemia (HP:0002149) | 2.35930846 |
| 75 | Increased purine levels (HP:0004368) | 2.35930846 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.34299527 |
| 77 | Skin nodule (HP:0200036) | 2.34293202 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.33931790 |
| 79 | Abnormal cartilage morphology (HP:0002763) | 2.29293949 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.27804358 |
| 81 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.27223422 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25672739 |
| 83 | Exercise-induced myalgia (HP:0003738) | 2.25515177 |
| 84 | Type I transferrin isoform profile (HP:0003642) | 2.25307708 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.25047472 |
| 86 | Chromsome breakage (HP:0040012) | 2.23424350 |
| 87 | Abnormality of alanine metabolism (HP:0010916) | 2.20679674 |
| 88 | Hyperalaninemia (HP:0003348) | 2.20679674 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.20679674 |
| 90 | Conjunctival hamartoma (HP:0100780) | 2.20625965 |
| 91 | Ragged-red muscle fibers (HP:0003200) | 2.20171842 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19461466 |
| 93 | Ventricular tachycardia (HP:0004756) | 2.18995425 |
| 94 | Multiple enchondromatosis (HP:0005701) | 2.17958270 |
| 95 | Increased CSF lactate (HP:0002490) | 2.17714558 |
| 96 | Progressive external ophthalmoplegia (HP:0000590) | 2.16862214 |
| 97 | Pancreatitis (HP:0001733) | 2.16835644 |
| 98 | Hyperglycemia (HP:0003074) | 2.16385957 |
| 99 | * Glycosuria (HP:0003076) | 2.16088384 |
| 100 | * Abnormality of urine glucose concentration (HP:0011016) | 2.16088384 |
| 101 | Hepatocellular carcinoma (HP:0001402) | 2.16030336 |
| 102 | Increased hepatocellular lipid droplets (HP:0006565) | 2.15381837 |
| 103 | Myocardial infarction (HP:0001658) | 2.14080209 |
| 104 | Cholelithiasis (HP:0001081) | 2.13084758 |
| 105 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10918107 |
| 106 | Exercise-induced muscle cramps (HP:0003710) | 2.10913376 |
| 107 | Increased mean platelet volume (HP:0011877) | 2.10651076 |
| 108 | Hypertriglyceridemia (HP:0002155) | 2.10484951 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.09734622 |
| 110 | Steatorrhea (HP:0002570) | 2.09659278 |
| 111 | Late onset (HP:0003584) | 2.09378700 |
| 112 | Sudden death (HP:0001699) | 2.09107558 |
| 113 | Petechiae (HP:0000967) | 2.08023438 |
| 114 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07730990 |
| 115 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07730990 |
| 116 | Renal Fanconi syndrome (HP:0001994) | 2.07390092 |
| 117 | Abnormality of the anterior horn cell (HP:0006802) | 2.05914773 |
| 118 | Degeneration of anterior horn cells (HP:0002398) | 2.05914773 |
| 119 | Muscle stiffness (HP:0003552) | 2.03862869 |
| 120 | Megaloblastic anemia (HP:0001889) | 2.03463848 |
| 121 | Macrocytic anemia (HP:0001972) | 2.03021898 |
| 122 | Neoplasm of head and neck (HP:0012288) | 2.01308993 |
| 123 | Esophageal neoplasm (HP:0100751) | 2.01308993 |
| 124 | Respiratory failure (HP:0002878) | 2.01149399 |
| 125 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98453521 |
| 126 | * Renal cortical cysts (HP:0000803) | 1.96143750 |
| 127 | Mitochondrial inheritance (HP:0001427) | 1.95831410 |
| 128 | Paralysis (HP:0003470) | 1.95765464 |
| 129 | Bundle branch block (HP:0011710) | 1.94729052 |
| 130 | Lipid accumulation in hepatocytes (HP:0006561) | 1.93914618 |
| 131 | Aplastic anemia (HP:0001915) | 1.93897495 |
| 132 | Menorrhagia (HP:0000132) | 1.89687934 |
| 133 | Acanthocytosis (HP:0001927) | 1.87050755 |
| 134 | Spontaneous abortion (HP:0005268) | 1.84033566 |
| 135 | Fasciculations (HP:0002380) | 1.82788479 |
| 136 | Reticulocytopenia (HP:0001896) | 1.82051448 |
| 137 | Hypokinesia (HP:0002375) | 1.80988432 |
| 138 | Testicular atrophy (HP:0000029) | 1.79831959 |
| 139 | Neck muscle weakness (HP:0000467) | 1.79354638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.27938174 |
| 2 | PDK4 | 3.54276259 |
| 3 | PDK3 | 3.54276259 |
| 4 | BUB1 | 3.48969710 |
| 5 | SCYL2 | 3.24859704 |
| 6 | TRIB3 | 3.09093792 |
| 7 | ERN1 | 2.86843844 |
| 8 | PKN2 | 2.71363445 |
| 9 | EIF2AK3 | 2.62093454 |
| 10 | SIK1 | 2.48084781 |
| 11 | ARAF | 2.41429502 |
| 12 | FGFR4 | 2.41304297 |
| 13 | MST4 | 2.33108493 |
| 14 | PDK2 | 2.21025220 |
| 15 | SRPK1 | 2.20788438 |
| 16 | TTN | 2.20316322 |
| 17 | NEK1 | 2.19067773 |
| 18 | TESK2 | 2.08750515 |
| 19 | OBSCN | 2.01172944 |
| 20 | NEK9 | 1.96483076 |
| 21 | FLT3 | 1.92689735 |
| 22 | STK38L | 1.91580966 |
| 23 | NME2 | 1.89139240 |
| 24 | CDC7 | 1.85090715 |
| 25 | MAP3K12 | 1.83438204 |
| 26 | VRK2 | 1.82101373 |
| 27 | MYLK | 1.78857748 |
| 28 | LMTK2 | 1.77808579 |
| 29 | RPS6KB2 | 1.73028739 |
| 30 | INSRR | 1.60606315 |
| 31 | PINK1 | 1.59712150 |
| 32 | PIM2 | 1.48188501 |
| 33 | TIE1 | 1.46956665 |
| 34 | MST1R | 1.45349208 |
| 35 | WEE1 | 1.42564369 |
| 36 | KDR | 1.41889762 |
| 37 | TESK1 | 1.39262067 |
| 38 | PIK3CG | 1.38195201 |
| 39 | MAP2K3 | 1.33488490 |
| 40 | PAK4 | 1.24793579 |
| 41 | MAPK11 | 1.24579681 |
| 42 | EEF2K | 1.23037195 |
| 43 | EIF2AK1 | 1.21233344 |
| 44 | LATS1 | 1.21004973 |
| 45 | MAP3K3 | 1.19449572 |
| 46 | CDK8 | 1.17001424 |
| 47 | PRKAA2 | 1.15838602 |
| 48 | IRAK3 | 1.14815919 |
| 49 | ABL2 | 1.13900087 |
| 50 | STK24 | 1.13434163 |
| 51 | CDK7 | 1.08942799 |
| 52 | TYK2 | 1.08309661 |
| 53 | PIK3CA | 1.07069286 |
| 54 | NME1 | 1.03268517 |
| 55 | AURKB | 1.03248937 |
| 56 | MAP3K9 | 1.01620938 |
| 57 | ERBB4 | 1.01294738 |
| 58 | TSSK6 | 1.01220458 |
| 59 | VRK1 | 1.00817606 |
| 60 | BRAF | 1.00585785 |
| 61 | AURKA | 0.98073673 |
| 62 | PHKG2 | 0.96697043 |
| 63 | PHKG1 | 0.96697043 |
| 64 | CCNB1 | 0.95690345 |
| 65 | TGFBR2 | 0.95552858 |
| 66 | LIMK1 | 0.94882558 |
| 67 | TRIM28 | 0.94848594 |
| 68 | PLK1 | 0.94629076 |
| 69 | MAP3K11 | 0.93471026 |
| 70 | WNK4 | 0.90297238 |
| 71 | RAF1 | 0.82488265 |
| 72 | PTK6 | 0.82412005 |
| 73 | CDK4 | 0.79321142 |
| 74 | PLK4 | 0.78572269 |
| 75 | PLK3 | 0.78517635 |
| 76 | PRKAA1 | 0.77785467 |
| 77 | TBK1 | 0.77428724 |
| 78 | MUSK | 0.74086506 |
| 79 | MAP3K8 | 0.72751410 |
| 80 | BRSK1 | 0.72723209 |
| 81 | CHEK2 | 0.71580465 |
| 82 | TLK1 | 0.71389055 |
| 83 | FRK | 0.70990951 |
| 84 | JAK2 | 0.67492179 |
| 85 | CDK9 | 0.67116693 |
| 86 | CDK6 | 0.67070212 |
| 87 | BMPR2 | 0.66380572 |
| 88 | EPHA3 | 0.66279395 |
| 89 | MAP3K5 | 0.64792549 |
| 90 | ZAK | 0.64683358 |
| 91 | MAPKAPK3 | 0.64668254 |
| 92 | MAP3K7 | 0.63367276 |
| 93 | TAOK3 | 0.63301720 |
| 94 | WNK3 | 0.62825362 |
| 95 | PRKCI | 0.60262390 |
| 96 | CHEK1 | 0.59369452 |
| 97 | MAPK12 | 0.58921388 |
| 98 | BMPR1B | 0.58572728 |
| 99 | CAMK1D | 0.57977539 |
| 100 | JAK1 | 0.56819888 |
| 101 | ACVR1B | 0.56373670 |
| 102 | ATR | 0.56258088 |
| 103 | MAP2K6 | 0.56048192 |
| 104 | STK4 | 0.53855312 |
| 105 | PRKACG | 0.53800927 |
| 106 | KSR2 | 0.53189045 |
| 107 | CSNK2A2 | 0.53153701 |
| 108 | DAPK3 | 0.52804220 |
| 109 | SMG1 | 0.52432240 |
| 110 | CSNK2A1 | 0.52305182 |
| 111 | EIF2AK2 | 0.52069509 |
| 112 | MAP2K1 | 0.51981248 |
| 113 | LRRK2 | 0.51794335 |
| 114 | TAOK2 | 0.51242665 |
| 115 | DAPK1 | 0.51198431 |
| 116 | CLK1 | 0.49481425 |
| 117 | MAPKAPK5 | 0.48042898 |
| 118 | ILK | 0.46833425 |
| 119 | STK3 | 0.44710450 |
| 120 | PAK1 | 0.44382840 |
| 121 | MAP2K4 | 0.44338199 |
| 122 | RPS6KA5 | 0.43477797 |
| 123 | MAP3K14 | 0.43218593 |
| 124 | TTK | 0.42425491 |
| 125 | RPS6KA4 | 0.40141422 |
| 126 | EPHB2 | 0.39812113 |
| 127 | EPHA2 | 0.39679330 |
| 128 | STK16 | 0.39392537 |
| 129 | TRPM7 | 0.39122706 |
| 130 | BRSK2 | 0.38964996 |
| 131 | GRK7 | 0.38891694 |
| 132 | PDPK1 | 0.38450470 |
| 133 | DYRK1B | 0.38377924 |
| 134 | PRKD1 | 0.37984012 |
| 135 | MAPK4 | 0.37528763 |
| 136 | TGFBR1 | 0.37522884 |
| 137 | CSNK1G3 | 0.36991235 |
| 138 | PBK | 0.36721157 |
| 139 | MET | 0.36482343 |
| 140 | FER | 0.36005702 |
| 141 | RIPK1 | 0.34671259 |
| 142 | ERBB3 | 0.32414349 |
| 143 | CAMK2D | 0.32303786 |
| 144 | IRAK1 | 0.32270571 |
| 145 | CAMK2G | 0.31483601 |
| 146 | GSK3A | 0.29664762 |
| 147 | AKT2 | 0.28539143 |
| 148 | PAK3 | 0.28006763 |
| 149 | LATS2 | 0.27796659 |
| 150 | NUAK1 | 0.27718578 |
| 151 | PRKG2 | 0.27565943 |
| 152 | IGF1R | 0.24694899 |
| 153 | FGFR3 | 0.24142776 |
| 154 | EPHB1 | 0.23114686 |
| 155 | MAPK15 | 0.22889689 |
| 156 | STK10 | 0.22881002 |
| 157 | MTOR | 0.22732501 |
| 158 | ERBB2 | 0.22103366 |
| 159 | PDK1 | 0.21846176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.37061523 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.30868253 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.26753091 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.20985858 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.13807018 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.09394112 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.91404673 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81729473 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63484501 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53925670 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43926154 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.42424525 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.37929405 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29466362 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.29427788 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21559265 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19396502 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14796431 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12495148 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.11156391 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 2.08362261 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.04958507 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99417817 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87113600 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76565229 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.75643532 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74031408 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71643565 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65497768 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54155859 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51904547 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51210664 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49949946 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49000734 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48678685 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48002308 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42365549 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.40122883 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.37152854 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36402103 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33552435 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33020899 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32393541 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31439509 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.27551038 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25404860 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22420253 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21479793 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19382253 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 1.15958162 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15830161 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14345178 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10477764 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09817826 |
| 55 | RNA transport_Homo sapiens_hsa03013 | 1.06257791 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98990696 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.96987694 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93666176 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92939690 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.92265937 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 0.91052990 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90288811 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90128872 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88809157 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87476100 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87039729 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.85164720 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83916601 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82993441 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.81265187 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80923203 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.77426817 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.76829374 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76203522 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76199842 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74609395 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.71699744 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68046392 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66520853 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65207454 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63443435 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62694840 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60941308 |
| 84 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57758626 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54712539 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54405075 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53761395 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53334746 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49338036 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.49333403 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48967717 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48828026 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47969652 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45618910 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44036418 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42321382 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.42204072 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38210812 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34411502 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33083671 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26775172 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25320416 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24149073 |
| 104 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.22749248 |
| 105 | Proteasome_Homo sapiens_hsa03050 | 0.21710110 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20067523 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18507010 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12033502 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10107210 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06913926 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05956902 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1389716 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1351891 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1344132 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1295923 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0932695 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0439385 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0437274 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | -0.0348366 |
| 120 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0314246 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0134548 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | -0.0078616 |
| 123 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0019216 |

